Testosterone Prescriptions for Women Surge Amid Pharmacy Access Barriers

A recent analysis found that testosterone prescriptions for women have nearly tripled in the past few years. AzmanL · E+/Getty A recent analysis found that testosterone prescriptions for females increased 146% between January 2023 and July 2026. There are currently no FDA-approved testosterone products specifically for females, which can create dosing and prescription access challenges. Current clinical guidance supports testosterone therapy for hypoactive sexual desire disorder (HSDD) in postmenopausal females. More research is needed to determine whether testosterone provides benefits for other menopause-related concerns, such as fatigue, mood, and muscle strength. Over the past few years, there has been a surge in prescriptions of testosterone for females experiencing menopause, according to an analysis by the research analytics company Truveta for Reuters that was published on September 15. However, these results have not been published in a scientific journal. The rise in prescriptions has also come amid reports of prescription delays and denials at pharmacies. This may be due in part to the fact that there are currently no testosterone products approved by the Food and Drug …

≈